CoChat

Cardiovascular and hemodynamic effects of glucagon-like peptide-1

Open access
Goodwill, Adam G., Mather, Kieren J., Conteh, Abass M., Sassoon, Daniel J., Noblet, Jillian N., Tune, Johnathan D. · 2014 · Reviews in Endocrine and Metabolic Disorders
Cited by 17

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Glucagon-like peptide-1 (GLP-1) is an incretin hormone that has been shown to have hemodynamic and cardioprotective capacity in addition to its better characterized glucoregulatory actions. Because of this, emerging research has focused on the ability of GLP-1 based therapies to drive myocardial substrate selection, enhance cardiac performance and regulate heart rate, blood pressure and vascular tone. These studies have produced consistent and reproducible results amongst numerous laboratories. However, there are obvious disparities in findings obtained in small animal models versus those of higher mammals. This species dependent discrepancy calls to question, the translational value of individual findings. Moreover, few studies of GLP-1 mediated cardiovascular action have been performed in the presence of a pre-existing comorbidities (e.g. obesity/diabetes) which limits interpretation of the effectiveness of incretin-based therapies in the setting of disease. This review addresses cardiovascular and hemodynamic potential of GLP-1 based therapies with attention to species specific effects as well as the interaction between therapies and disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11154-014-9290-z

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 21 references

Cited by

See all 17

Metadata

Authors
Goodwill, A. G., Mather, K. J., Conteh, A. M., Sassoon, D. J., Noblet, J. N., & Tune, J. D.
Venue
Reviews in Endocrine and Metabolic Disorders
Published
2014-06-03
Volume
15
Issue
3
Pages
209-217
ISSN
  • 1389-9155 (ISSN-L)
  • 1573-2606
OpenAlex
W2012627173
Cited by
17
References
21
FWCI
2.15
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardiovascular and hemodynamic effects of glucagon-like peptide-1. https://app.cochat.ai/papers/10.1007/s11154-014-9290-z
The paper
Goodwill, A. G., Mather, K. J., Conteh, A. M., Sassoon, D. J., Noblet, J. N., & Tune, J. D. (2014). Cardiovascular and hemodynamic effects of glucagon-like peptide-1. Reviews in Endocrine and Metabolic Disorders. https://doi.org/10.1007/s11154-014-9290-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.